(Q30638921)

English

Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the A

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the A (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

J Kjekshus

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

author name string

K Dickstein

1

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan

3

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

766-71, A7

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Inhibition of the renin-angiotensin system after acute myocardial infarction--treat first, select later?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901500-9

7 January 2021

Identifiers

10.1016/S0002-9149(00)01500-9

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30638921&oldid=1582922766"